{
    "clinical_study": {
        "@rank": "28318", 
        "arm_group": {
            "arm_group_label": "Umbilical cord blood therapy", 
            "arm_group_type": "Experimental", 
            "description": "Allogeneic umbilical cord blood will be administered intravenously or intraarterially under non-myeloablative immunosuppression. In case of autologous umbilical cord blood, immunosuppression is not required."
        }, 
        "brief_summary": {
            "textblock": "This open-label study aims to evaluate the safety and efficacy of autologous or allogeneic\n      umbilical cord blood therapy for children with global developmental delay."
        }, 
        "brief_title": "Umbilical Cord Blood Therapy for Global Developmental Delay", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Global Developmental Delay", 
        "detailed_description": {
            "textblock": "Global developmental delay is defined as significant delay in two or more of the following\n      developmental domains: gross/fine motor, speech/language, cognition, social/personal, and\n      activities of daily living.\n\n      Umbilical cord blood has been used for inherited metabolic diseases that feature global\n      developmental delay and many experimental animal studies have revealed umbilical cord blood\n      is useful to repair neurological impairments in brain."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Global developmental delay\n\n          -  Willing to comply with all study procedure\n\n        Exclusion Criteria:\n\n          -  Medical instability including pneumonia or renal function at enrollment\n\n          -  Poor cooperation of guardian,including inactive attitude for rehabilitation and\n             visits for follow-up\n\n          -  Uncontrolled persistent epilepsy\n\n          -  Not eligible according to the principal investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01769716", 
            "org_study_id": "UCBGDD"
        }, 
        "intervention": {
            "arm_group_label": "Umbilical cord blood therapy", 
            "intervention_name": "Umbilical Cord Blood administration", 
            "intervention_type": "Procedure", 
            "other_name": "Autologous or Allogeneic Umbilical Cord Blood"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Global developmental delay", 
            "Umbilical cord blood", 
            "Rehabilitation"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "contact": {
                "email": "kmin@cha.ac.kr", 
                "last_name": "MinYoung Kim, M.D., Ph.D.", 
                "phone": "82-31-780-6281"
            }, 
            "contact_backup": {
                "email": "minkh@chamc.co.kr", 
                "last_name": "Kyunghoon Min, M.D.", 
                "phone": "82-31-780-6281"
            }, 
            "facility": {
                "address": {
                    "city": "Seongnam-si", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeonggi-do", 
                    "zip": "463-712"
                }, 
                "name": "CHA Bundang Medical Center, CHA University"
            }, 
            "investigator": [
                {
                    "last_name": "MinYoung Kim, M.D., Ph.D.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Myung Seo Kang, M.D., Ph.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sang Heum Kim, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Su Jin Jang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Kyunghoon Min, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Su Jin Yoo, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Umbilical Cord Blood Therapy for Children With Global Developmental Delay", 
        "overall_contact": {
            "email": "kmin@cha.ac.kr", 
            "last_name": "MinYoung Kim, M.D., Ph.D.", 
            "phone": "82-31-780-6281"
        }, 
        "overall_contact_backup": {
            "email": "minkh@chamc.co.kr", 
            "last_name": "Kyunghoon Min, M.D.", 
            "phone": "82-31-780-6281"
        }, 
        "overall_official": {
            "affiliation": "CHA University", 
            "last_name": "MinYoung Kim, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Korean Wechsler Preschool and Primary Scale of Intelligence (K-WPPSI) (Higher value means better cognitive function (K-WPPSI: below 70 - worst, over 130 - best)", 
                "measure": "Changes in Cognition", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 6 months - 12 months"
            }, 
            {
                "description": "Korean version of Bayley Scale of Infant Development-II Mental Scales (Higher value means better cognitive function: raw score 0 - worst, 178 - best.)", 
                "measure": "Changes in Cognitive Neurodevelopmental Outcome", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01769716"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bundang CHA Hospital", 
            "investigator_full_name": "MinYoung Kim, M.D.", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "GMPM (Gross Motor Performance Measure) as a standardized measurement tool for assessing quality of movement regarding 3 properties of 5 ones; alignment, coordination, dissociated movement, stability, and weight shift (range: 0~100, Higher value means better motor quality.)", 
                "measure": "Changes in Motor Performance", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "GMFM (Gross Motor Function Measure) as a standardized measurement tool for assessing Gross Motor Function consisting of sub-scales; lying & rolling, sitting, crawling & kneeling, standing, walking, running & jumping (range: 0~100 , Higher value means better gross motor function.)", 
                "measure": "Changes in Standardized Gross Motor Function", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "Korean version of Bayley Scale of Infant Development-II Motor Scales (Higher value means better motor function: raw score 0 - worst, 112 - best)", 
                "measure": "Changes in Motor Neurodevelopmental Outcome", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "WeeFIM (Functional Independence Measure for Children) measures functional independence in daily activities. WeeFIM contains 18 items and each item is ranked from complete dependence (scored as 1) to complete independence (scored as 7). The range is from 18 to 126 and higher scores mean more independent performance in daily activities.", 
                "measure": "Changes in Functional Independence in Daily Activities", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "Visual perception function is evaluated with one of three measures: DTVP (Developmental Test of Visual Perception), MVPT (Motor-free Visual Perception Test), and VMI (Visual-Motor Integration). All can be scored as percentile rank from 0 to 100. Higher values mean better visual perception ability.", 
                "measure": "Changes in Visual Perception Test", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "Summation of MMT (manual muscle testing): summated scores of the manual muscle strength test (zero=0, trace=1, poor=2, fair=3, good=4, normal=5) for flexors, extensors, abductors, and adductors of bilateral shoulder and hip joints; flexors and extensors of bilateral elbow, wrist, and knee; dorsiflexors and plantar flexors of the ankles (range: 0 ~ 160). Higher scores mean better muscle strength.", 
                "measure": "Changes in Muscle Strength", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "Pediatric Evaluation of Disability Inventory (PEDI) for assessing functional performance in daily activities in children (All values are adjusted and higher value means better functional performance, 0 - worst, 100 - best.)", 
                "measure": "Changes in Functional Performance in Daily Activities", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 1 month - 3 months - 6 months - 12 months"
            }, 
            {
                "description": "Sequenced Language Scale for Infant (SELSI), Preschool Receptive-Expressive Language Scale (PRES) or Korean Western Aphasia Battery (K-WAB)", 
                "measure": "Changes in Language Evaluation", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 6 months - 12 months"
            }, 
            {
                "description": "FDG-PET", 
                "measure": "Changes in Brain glucose metabolism", 
                "safety_issue": "No", 
                "time_frame": "Baseline - 12 months"
            }
        ], 
        "source": "Bundang CHA Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "CHA University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "MinYoung Kim, M.D.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}